Field-assisted paper spray mass spectrometry for therapeutic drug monitoring: 1. the case of imatinib in plasma

被引:3
|
作者
D'Aronco, S. [1 ]
Dall'Armi, M. [2 ]
Crotti, S. [1 ]
Calandra, E. [1 ]
Traldi, P. [1 ]
Di Marco, V. [2 ]
Buonadonna, A. [3 ]
Corona, G. [3 ]
Giodini, L. [3 ]
Marangon, E. [3 ]
Posocco, B. [3 ]
Toffoli, G. [3 ]
Agostini, M. [1 ,4 ]
机构
[1] Inst Paediat Res Citta Speranza, Nanoinspired Biomed Lab, Corso Stati Uniti 4, I-35127 Padua, Italy
[2] Univ Padua, Dept Chem Sci, Via Marzolo 1, I-35131 Padua, Italy
[3] IRCCS, Natl Canc Inst, Ctr Riferimento Oncol, Expt & Clin Pharmacol Unit, Via Franco Gallini 2, I-33081 Aviano, PN, Italy
[4] Univ Padua, Surg Clin, Dept Surg Oncol & Gastroenterol Sci, Via Nicolo Giustiniani 2, I-35128 Padua, Italy
来源
JOURNAL OF MASS SPECTROMETRY | 2017年 / 52卷 / 05期
关键词
imatinib; paper spray; comparison PS and LC-MS/MS; therapeutic drug monitoring; imatinib in plasma; PHARMACOKINETICS; QUANTIFICATION; METABOLITES; RESPONSES; BLOOD; ASSAY;
D O I
10.1002/jms.3927
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The field-assisted paper spray (FAPS) - mass spectrometric method has been employed to quantify the imatinib (IMT) plasma levels in treated patients. The quantitative measurements have been performed on the collisionally generated fragment at m/z 394 of the protonated molecules of IMT and deuterated IMT (d(3)-IMT), used as internal standard. The FAPS-tandem mass spectrometry (MS/MS) method exhibits some limitations, because of the high number of operative parameters that need to be carefully controlled. For this aim, papers of different geometry, thickness, and porosity were tested. To obtain a more focalized and intense electrical field, a stainless steel needle was mounted axially and placed at 4 kV voltage. The variability observed in the measurements was ascribed either to the inter-individual variability (e.g. the concomitant presence of other compounds such as proteins, lipids, drugs and/or salts in the plasma of different patients) or to the uncontrollable variables in the instrumental setup (e.g. sample deposition, changes in paper spray conditions). Furthermore, the manual sample deposition and solvent dripping strongly affects the measure reproducibility. Despite this, it is interesting to observe that, once applied in blind on 24 real plasma samples, FAPS-MS/MS led to results analogous to those obtained by the well-consolidated liquid chromatography-MS/MS, even if the mean coefficient of variation % (CV%) values of 20.4% and 2.6% were observed for the two methods, respectively. In conclusion, despite CV values are relatively high, it is worth noting that the FAPS-MS/MS method is much more straightforward, rapid and economical than the liquid chromatography-MS/MS one, and it appears therefore very promising for applicationswhere a high precision is not always a required task, as e.g. in some cases of therapeutic drug monitoring. Copyright (C) 2017 John Wiley & Sons, Ltd.
引用
收藏
页码:283 / 289
页数:7
相关论文
共 50 条
  • [21] Quantification of 11 Therapeutic Kinase Inhibitors in Human Plasma for Therapeutic Drug Monitoring Using Liquid Chromatography Coupled With Tandem Mass Spectrometry
    Herbrink, Maikel
    de Vries, Niels
    Rosing, Hilde
    Huitema, Alwin D. R.
    Nuijen, Bastiaan
    Schellens, Jan H. M.
    Beijnen, Jos H.
    THERAPEUTIC DRUG MONITORING, 2016, 38 (06) : 649 - 656
  • [22] New ionization methods and miniature mass spectrometers for biomedicine: DESI imaging for cancer diagnostics and paper spray ionization for therapeutic drug monitoring
    Cooks, R. Graham
    Manicke, Nicholas E.
    Dill, Allison L.
    Ifa, Demian R.
    Eberlin, Livia S.
    Costa, Anthony B.
    Wang, He
    Huang, Guangming
    Zheng Ouyang
    FARADAY DISCUSSIONS, 2011, 149 : 247 - 267
  • [23] Simultaneous quantification of imatinib and its main metabolite N-demethyl-imatinib in human plasma by liquid chromatography-tandem mass spectrometry and its application to therapeutic drug monitoring in patients with gastrointestinal stromal tumor
    Zhuang, Wei
    Qiu, Hai-Bo
    Chen, Xin-Meng
    Yuan, Xiu-Hong
    Yang, Li-Fang
    Sun, Xiao-Wei
    Zhou, Xiao-Jun
    Huang, Min
    Wang, Xue-Ding
    Zhou, Zhi-Wei
    BIOMEDICAL CHROMATOGRAPHY, 2017, 31 (12)
  • [24] Liquid chromatography high resolution mass spectrometry for the determination of baclofen and its metabolites in plasma: Application to therapeutic drug monitoring
    Labat, Laurence
    Goncalves, Antonio
    Marques, Ana Rita
    Duretz, Benedicte
    Granger, Bernard
    Decleves, Xavier
    BIOMEDICAL CHROMATOGRAPHY, 2017, 31 (08)
  • [25] Quantification of mycophenolic acid in human plasma by liquid chromatography with time-of-flight mass spectrometry for therapeutic drug monitoring
    Antunes, Natalicia J.
    Ince, Nina
    Raymond, Jason
    Kipper, Karin
    Couchman, Lewis
    Holt, David W.
    De Nucci, Gilberto
    Johnston, Atholl
    BIOMEDICAL CHROMATOGRAPHY, 2021, 35 (03)
  • [26] Analysis of gabapentin in serum and plasma by solid-phase extraction and gas chromatography mass spectrometry for therapeutic drug monitoring
    Kushnir, MM
    Crossett, J
    Brown, PI
    Urry, FM
    JOURNAL OF ANALYTICAL TOXICOLOGY, 1999, 23 (01) : 1 - 6
  • [27] A simple and green capillary electrophoresis-mass spectrometry method for therapeutic drug monitoring of colistin in clinical plasma samples
    Cizmarova, Ivana
    Parrak, Vojtech
    Secnik, Peter, Jr.
    Secnik, Peter
    Sopko, Ladislav
    Nemergutova, Kristina
    Kovac, Andrej
    Mikus, Peter
    Piestansky, Juraj
    HELIYON, 2023, 9 (12)
  • [28] Validation of atovaquone plasma levels by liquid chromatography-tandem mass spectrometry for therapeutic drug monitoring in pediatric patients
    Horvath, Thomas D.
    Poventud-Fuentes, Izmarie
    Olayinka, Lily
    James, Asha
    Haidacher, Sigmund J.
    Hoch, Kathleen M.
    Stevens, Alexandra M.
    Haag, Anthony M.
    Devaraj, Sridevi
    JOURNAL OF MASS SPECTROMETRY AND ADVANCES IN THE CLINICAL LAB, 2022, 26 : 23 - 27
  • [29] Relevance of a combined UV and single mass spectrometry detection for the determination of tenofovir in human plasma by HPLC in therapeutic drug monitoring
    El Barkil, Mirna
    Gagnieu, Marie-Claude
    Guitton, Jerome
    JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2007, 854 (1-2): : 192 - 197
  • [30] Quantification of imatinib in human serum: validation of a high-performance liquid chromatography-mass spectrometry method for therapeutic drug monitoring and pharmacokinetic assays
    Rezende, Vinicius Marcondes
    Rivellis, Ariane
    Yoshinaga Novaes, Mafalda Megumi
    Fisher Chamone, Dalton de Alencar
    Bendit, Israel
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2013, 7 : 699 - 710